recombinant

(redirected from interferon alfa-2b)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to interferon alfa-2b: interferon alpha, interferon alfa-2a, Intron A

re·com·bi·nant

 (rē-kŏm′bə-nənt)
n.
1. An organism, cell, or virus in which genetic recombination has taken place.
2. Material produced by genetic engineering.
adj.
1. Formed by or showing recombination: a recombinant chromosome.
2. Of or relating to recombinant DNA: recombinant fragments; recombinant technology.

recombinant

(riːˈkɒmbɪnənt) genetics
adj
(Genetics) produced by the combining of genetic material from more than one origin
n
(Genetics) a chromosome, cell, organism, etc, the genetic makeup of which results from recombination

re•com•bi•nant

(riˈkɒm bə nənt)
adj.
1. of or resulting from new combinations of genetic material: recombinant cells.
n.
2. a cell or organism whose genetic material results from recombination.
3. the genetic material produced when segments of DNA from different sources are joined to produce recombinant DNA.
[1940–45]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.recombinant - a cell or organism in which genetic recombination has occurred
organism, being - a living thing that has (or can develop) the ability to act or function independently
cell - (biology) the basic structural and functional unit of all organisms; they may exist as independent units of life (as in monads) or may form colonies or tissues as in higher plants and animals
Adj.1.recombinant - of or relating to recombinant DNA
Translations

recombinant

adj recombinante
References in periodicals archive ?
Electronic auction: delivery of the drug interferon alfa-2b, designed to provide children under the age of 3 years and children from large families under the age of 6 years, according to free prescriptions of gphu "city children~s polyclinic" in 2018
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial.
Peginterferon alfa-2b plus Ribavirin compared with interferon alfa-2b plus Ribavirin for initial treatment of chronic hepatitis C: a randomised trial.
WAIKOLOA, HAWAII -- Intralesional injection of interferon alfa-2b is an excellent option for the treatment of large problematic basal cell carcinomas in patients who aren't interested in the higher-morbidity options, Dr.
700 Eprex EPO, rDNA J&J $657 PEG-Intron Interferon alfa-2b, Merck & Co.
In an anemia management subanalysis of a study comparing sustained virologic response (SVR) rates in cirrhotic and noncirrhotic patients treated with boceprevir (Victrelis), pegylated interferon alfa-2b (Peg-Intron), and ribavirin (RBV), 57% of patients with cirrhosis and anemia treated with a ribavirin dose reduction had an SVR, compared with 64% of those treated with erythropoietin.
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.
1,2) The non-approved drugs--pegylated interferon alfa-2b, emtricitabine, and a combination of emtricitabine and tenofovir--have also been used to treat chronic HBV infection.